Long-term safety and survival time under subcutaneous treprostinil treatment in patients with severe chronic thromboembolic pulmonary hypertension (CTEPH) - Milan 2023

Chronic thromboembolic pulmonary hypertension and other aspects in the pulmonary vasculature

Chair(s): Frederic Lador, Mitja Jevnikar

Session type: Poster session

Long-term safety and survival time under subcutaneous treprostinil treatment in patients with severe chronic thromboembolic pulmonary hypertension (CTEPH)

Pavel Jansa

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Pattern of lung function impairment in patients suffer from chronic thromboembolic pulmonary hypertension

Axel Kempa

Poster

Abstract

Long-term safety and survival time under subcutaneous treprostinil treatment in patients with severe chronic thromboembolic pulmonary hypertension (CTEPH)

Pavel Jansa

Poster

Abstract

Chest computed tomography demonstrates transient enlargement of the pulmonary artery in COVID-19 pneumonia that regresses after remission of the disease

Nikoleta Bizymi

Poster

Abstract

Characteristics in patients with inoperable CTEPH and a good hemodynamic outcome post-BPA

Mitja Jevnikar

Poster

Abstract

Left ventricular diastolic dysfunction attenuates outcomes in CTEPH

Katherine Bunclark

Poster

Abstract

The relationship between the preoperative pulmonary function test and DLCO values and the anatomical classification of thrombus in patients who underwent pulmonary endarterectomy with the diagnosis of chronic thromboembolic pulmonary hypertension.

Burcu Turan

Poster

Abstract

COVID-19 and pulmonary vasculature; the impact of pulmonary artery dilation in clinical outcome

Angelos Zouglos

Poster

Abstract

Renal outcomes after lung and combined heart-lung transplantation in pulmonary hypertension

Laura Hardy

Poster

Abstract

An open-source tool for risk prediction in operable CTEPH

Katherine Bunclark

Poster

Abstract

The impact of the Covid-19 pandemic on the lives of patients with pulmonary hypertension

Iain Armstrong

Abstract

Calibrated automated thrombography demonstrates a hypocoagulable profile in subjects with pulmonary arterial hypertension

Sarah Cullivan

Poster

Abstract

The effect of mechanical stimulation on cardiac fibroblasts in pulmonary arterial hypertension

Fjodor Bekedam

Poster

Abstract

Nocturnal desaturation in patients with chronic thromboembolic pulmonary hypertension.

Yu Taniguchi

Poster

Abstract

Bleeding under anticoagulant therapy in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: preliminary results from the HEMA-HTP study.

Souad Bezzeghoud

Poster

Abstract

Assessment of usability and flow profiles of patients with pulmonary hypertension inhaling with a high-resistance Soft Mist Inhaler (SMI)

Bernhard Mullinger

Poster

Abstract

A screening program for chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary embolism in SARS-CoV-2.

Lucilla Piccari

Poster

Abstract

CTEPH patients with mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic disease.

Coen Van Kan

Poster

Abstract

Extracellular microvesicles in animal model of postembolic pulmonary hypertension and in patients with pulmonary embolism and chronic thromboembolic pulmonary hypertension

Elva Maria Mendoza Zambrano

Poster

Abstract

Long-term effects of pulmonary endarterectomy on cardiopulmonary hemodynamics and exercise capacity in chronic thromboembolic pulmonary hypertension: London and Amsterdam experience

Andrea Baccelli

Poster

Abstract

Late Breaking Abstract - Metabolic phenotype determines outcome of pulmonary arterial hypertension

Andrea Olschewski

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}